# Can Semax protect heart function after myocardial infarction?

Canonical source: https://retacompare.com/research/can-semax-protect-heart-function-after-myocardial-infarction

Peptide Longevity Q&A · 2006-11-01


    Research indicates that Semax can exert a protective effect on heart function following myocardial infarction in rats. It partially prevents left ventricular pressure growth and ameliorates cardiomyocyte hypertrophy, suggesting potential benefits for cardiac health in the context of ischemic damage.

 What the research shows

The study investigated the effects of Semax, a peptide derived from ACTH, on heart function after inducing myocardial infarction (MI) in a rat model. The rats underwent coronary artery occlusion, and Semax was administered at specific intervals post-occlusion. The researchers evaluated cardiac hypertrophy, mean arterial blood pressure, left ventricular end-diastolic pressure, and contractile function 28 days post-MI. The findings indicated that Semax did not alter cardiac work but had a beneficial effect on left ventricular remodeling and heart failure development.

 Why it matters for longevity

Protecting heart function is crucial for maintaining overall health and longevity, particularly as age-related cardiovascular issues become more prevalent. The research demonstrates that Semax can mitigate some of the adverse effects of myocardial infarction, which may contribute to better heart health and potentially extend healthspan. By addressing cardiac hypertrophy and improving left ventricular function, Semax may play a role in supporting cellular longevity in cardiac tissues affected by ischemic damage.

 Key findings at a glance

Semax was administered to rats after inducing myocardial infarction.

The peptide partially prevented growth in left ventricular end-diastolic pressure.

Cardiac hypertrophy was ameliorated by Semax treatment.

Semax did not affect overall cardiac work.

The study suggests benefits for left ventricular remodeling post-MI.

Research indicates potential protective effects against ischemic damage.

 How Semax works (background)

Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH) that has been shown to have neuroprotective effects, particularly in the context of ischemic stroke. Its mechanism may involve modulation of neuroinflammation and enhancement of neurotrophic factors, which can contribute to cellular repair and regeneration. In the context of cardiac function, Semax appears to influence the remodeling process of the heart post-infarction, potentially by improving energy supply and reducing hypertrophic responses in cardiomyocytes.

 Safety, caveats, and what we don't yet know

While the study provides insights into the effects of Semax on heart function after myocardial infarction, it is important to note that this research was conducted in a preclinical model (rats). The translation of these findings to human populations requires further investigation. Additionally, the long-term safety and efficacy of Semax in various clinical settings, including its potential interactions with other treatments or conditions, remain to be fully understood. More research is needed to explore these aspects and to identify the optimal dosing and timing for therapeutic use.

 Bottom line

In summary, Semax shows promise in protecting heart function following myocardial infarction in research models, suggesting potential benefits for cardiac health and longevity.

 Related questions

 Does Semax support mitochondrial function in aging muscle tissue?

Research indicates that Semax may influence mitochondrial function, though specific studies on aging muscle tissue are limited. Its neuroprotective properties suggest potential benefits in cellular energy dynamics.

 What are the effects of Semax on neuroinflammation?

Semax has been shown to decrease neuroinflammation in the context of ischemic stroke, indicating its potential role in managing conditions associated with neuroinflammation and aging.

 Can Semax enhance recovery after stroke?

Yes, Semax has demonstrated efficacy in reducing neurological deficits after ischemic stroke in preclinical studies, highlighting its potential for enhancing recovery in affected patients.

 Source: PubMed · Ross Fiziol Zh Im I M Sechenova · published 2006-11-01.

## Sources

- PubMed · Ross Fiziol Zh Im I M Sechenova: https://pubmed.ncbi.nlm.nih.gov/17385423/